Bunkerhill ECG-EF vs Study Watch
AI Verdict
Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if your primary goal is to rapidly screen for reduced left ventricular ejection fraction (LVEF) in a clinical setting using routine 12-lead ECGs. This software-only AI algorithm seamlessly integrates with existing EHRs and ECG management systems, providing an efficient, non-invasive method for early identification of patients at risk for heart failure during standard care workflows.
View Bunkerhill ECG-EF →Choose Study Watch if…
Choose Verily Study Watch if you require continuous, multi-sensor physiological data collection for participants in clinical research studies. This prescription-only wearable device is ideal for long-term monitoring of parameters like ECG, heart rate, and movement, with data securely uploaded to Verily's cloud platform for in-depth analysis to support research objectives.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill ECG-EF | Study Watch |
|---|---|---|
| Pricing | Contact sales for pricing details. | Unknown |
| Deployment | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill ECG-EFBunkerhill ECG-EF is a software-only solution designed for seamless integration with existing EHRs and clinical workflows, minimizing disruption for healthcare providers and reducing the learning curve. In contrast, Verily Study Watch is a wearable device that requires patient compliance for continuous monitoring and data upload, introducing an additional layer of user interaction and potential adherence challenges for patients.
Clinical Value
Bunkerhill ECG-EFBunkerhill ECG-EF offers direct and immediate clinical value by enabling early identification of a critical heart failure risk factor (reduced LVEF) from routine ECGs, facilitating proactive intervention at scale. While Verily Study Watch provides valuable continuous monitoring data for clinical research and has shown promise in detecting conditions like AFib and Parkinson's symptoms, its primary stated purpose is for research and generating real-world evidence, rather than widespread diagnostic aid in routine clinical practice.
Pricing & Value
TieBoth Bunkerhill ECG-EF and Verily Study Watch have non-transparent pricing models, requiring direct contact with the vendor for specific details. Without publicly available information on costs or detailed pricing structures, it is not possible to conduct a meaningful head-to-head comparison of their pricing and overall value proposition.
Enterprise Readiness
Bunkerhill ECG-EFBunkerhill ECG-EF demonstrates strong enterprise readiness with clear FDA clearance, HIPAA compliance, BAA availability, and seamless integration with EHRs and clinical workflows. Verily Study Watch, despite being FDA-cleared and stating HIPAA compliance, faces an ongoing lawsuit alleging HIPAA violations and delayed breach notifications, which presents a significant risk and concern for enterprise adoption.
Innovation
Bunkerhill ECG-EFBunkerhill ECG-EF demonstrates higher innovation by integrating generative AI for comprehensive clinical reasoning and automated actions within existing workflows, extending beyond simple detection to proactive patient management. While Verily Study Watch is innovative in continuous multi-sensor data collection for research, Bunkerhill's approach to leveraging ubiquitous ECG data with advanced AI for actionable clinical insights and workflow automation represents a more profound transformation of routine care.
Support & Docs
Study WatchVerily Study Watch has publicly available support resources, including documentation, tutorials, and contact options for its related platforms like Data Workbench and Site CTMS, as well as regulatory information for the Study Watch itself. In contrast, specific details regarding customer support and comprehensive documentation for Bunkerhill ECG-EF are not readily available in the provided information or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill ECG-EF | Study Watch |
|---|---|---|
| Name | Bunkerhill ECG-EF | Study Watch |
| Company | BunkerHill Health | Verily Life Sciences |
| Description | FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. |
| Key Feature 1 | AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) | Continuous physiological monitoring |
| Key Feature 2 | Analyzes routine 12-lead ECG data | Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements) |
| Key Feature 3 | Software-only medical device | Long battery life (up to one week) |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Study Watch.